Compound panax notoginseng cataplasma

A technology of compound panax notoginseng and babu agent, applied in the directions of anti-inflammatory agents, pharmaceutical formulations, non-central analgesics, etc., can solve the problems of prone to allergic reactions, gastrointestinal discomfort of patients, poor patient compliance, etc., to avoid Liver first-pass effect, favorable for transdermal absorption, and long-lasting effect of drug action

Inactive Publication Date: 2007-09-19
KPC PHARM INC
View PDF0 Cites 10 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Because raw powder of medicinal materials is used as medicine, and the active ingredients of Aconitum Diancao, Chonglou, and Jintiesuo in the prescription have obvious liver first-pass effects. In addition, Aconitum Diancao, Chonglou, and Jintiesuo in the prescription are toxic traditional Chinese medicines, so the two The disadvantage of this preparation product is that there are large gastrointestinal side effects when taken orally, and some patients may experience reactions such as nausea, vomiting, and gastrointestinal discomfort, and the bioavailability is low, which limits the wide application of the drug in clinical practice to some extent.
Although the four medicinal materials in the liniment, Sanqi, Diancaowu, Jintiesuo, and Zhonglou, are extracted by percolation with 60% ethanol, the drug loading of the liniment is small, and the drug is easily wiped off by clothes, etc., and the effect is not long-lasting. Therapeutic effect can be achieved by repeated administration
In addition, since the liniment contains a large amount of ethanol, patients who are allergic to ethanol are prone to allergic reactions
Secondly, the liniment has poor stability. After standing for a period of time, there will be gelatinous substances deposited on the bottom of the bottle, which will have a certain impact on the quality, image and effect of the product; and because the use of the liniment will pollute the clothes, it is inconvenient to use and poor patient compliance.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Compound panax notoginseng cataplasma
  • Compound panax notoginseng cataplasma

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0061] Backing layer: non-woven fabric

[0062] Cover lining: polyester film

[0063] The composition of the medicated ointment layer is as follows by weight:

[0064] Compound Panax notoginseng extract (micronized dry extract powder) 1.5g

[0065] Gelatin 1.5g

[0066] Tragacanth Gum 1.5g

[0067] Macrogol-400 1.3g

[0068] Polyacrylic acid 1.0 g

[0069] Glycerin 0.5g

[0070] Zinc oxide 0.53 g

[0071] Azone 0.2g

[0072] borneol 0.05g

[0073] water 7 grams

[0074] Preparation method: crush the extract of compound notoginseng, weigh gelatin and tragacanth gum according to the prescription, add water, heat in a water bath to dissolve, mix polyacrylic acid, glycerin and zinc oxide evenly, add to the above glue, stir and mix evenly , then add polyethylene glycol-400 to disperse the suspension of borneol and compound notoginseng extract, and finally add azone to obtain a paste. Then spread it evenly on the non-woven fabric, cover it with a polyester film, and cut i...

Embodiment 2

[0077] Backing layer: non-woven fabric

[0078] Cover lining: aluminum foil-polyethylene composite film

[0079] The composition of the medicated ointment layer is as follows by weight:

[0080] Compound Panax notoginseng extract (dry extract powder) 1.0g

[0081] Sodium Polyacrylate 2.0g

[0082] Gelatin 1.5g

[0083] 1.5 g polyvinyl alcohol

[0084] Glycerin 2.0g

[0085] Zinc oxide 0.7 g

[0086] Azone 0.3g

[0087] Propylene Glycol 1.0g

[0088] Menthol 0.06g

[0089] water 17.0g

[0090] Preparation method: crush the extract of compound notoginseng, weigh gelatin, sodium polyacrylate, and polyvinyl alcohol according to the prescription, add water to make swelling, stir and mix evenly, mix glycerin, zinc oxide, and azone evenly, add the above swelling In the liquid, stir and mix evenly, then add the suspension liquid in which the menthol and compound Sanqi extract are dispersed with propylene glycol and azone to obtain a paste. Then spread it evenly on the non-wov...

Embodiment 3

[0093] Backing layer: non-woven fabric

[0094] Lid lining: Polyethylene film

[0095] The composition of the medicated ointment layer is as follows by weight:

[0096] Compound Panax notoginseng extract (micronized dry extract powder) 0.8g

[0097] Sodium polyacrylate 1.8g

[0098] Carbomer 934p 0.3g

[0099] Glycerin 5.3g

[0100] Propylene Glycol 1.4g

[0101] Kaolin 1.8g

[0102] Citric acid 0.04g

[0103] Aluminum trichloride 0.08 g

[0104] Menthol 0.07g

[0105] Purified water 25.0g

[0106] Preparation method: 1) Weigh sodium polyacrylate and carbomer according to the prescription amount, add water to make swelling, add aluminum trichloride, stir and mix evenly; 2) Mix glycerin and kaolin and add to 1; 3) Use propylene glycol to dissolve mint Brain and compound Panax notoginseng extract powder were dissolved into a suspension and added to 2; 4) Finally, citric acid was added, stirred and mixed evenly to obtain a paste. Then spread it evenly on the non-woven ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a compound external preparation of pseudo-ginseng, that is cataplasm, which is prepared by raw materials of extract (dry extract powder) of pseudo-ginseng, preserved Yunnan Kusnezoff monkshood, paris and psammosilene tunicoides with proper accessories. The compound cataplasm of the invention comprises a backing layer, a body containing ointment and a cover underlayer. The containing ointment body as a main part is formed by extract of pseudo-ginseng, preserved Yunnan Kusnezoff monkshood, paris and psammosilene tunicoides, with accessories such as adhesive, filer, penetration enhancers, humectant, etc., based on a predetermined ratio. The cataplasm has advantages of fast absorption, good moisture retention and ventilation property, and is comfortable for using. In addition, the product of the invention is convenient for using, has little acrimony to skin and has high compliance for patient.

Description

technical field [0001] The invention relates to the technical field of medicines, in particular to a compound notoginseng (external dosage form) cataplasm for treating various pains and having certain anti-inflammatory, antipyretic and local anesthetic effects. Background technique [0002] Catapult is an external preparation that dissolves or mixes drugs in a natural or synthetic water-soluble polymer matrix and spreads them on the backing material for sticking on the skin. It can act systemically or locally through transdermal absorption. It is also a transdermal drug delivery preparation, and its prototype is "poultica". Due to the rapid development of modern fine chemical industry and polymer material science, more excipients with superior performance have been provided for pharmacy. Therefore, cataplasm was first successfully developed by Japan in the 1970s. Up to now, a large number of cataplasms have been launched in developed countries such as Europe, America and J...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/258A61K9/70A61P29/00A61K125/00
Inventor 丁江生
Owner KPC PHARM INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products